BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 28816917)

  • 1. Factors Associated with Developmental Behavioral Pediatricians Prescribing Psychotropic Medication to Children with Autism Spectrum Disorder: A Study of Three DBPNet Sites.
    Jackel C; Shults J; Wiley S; Meinzen-Derr J; Augustyn M; Blum N
    J Dev Behav Pediatr; 2017 Oct; 38(8):584-592. PubMed ID: 28816917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Attention-Deficit/Hyperactivity Disorder by Developmental-Behavioral Pediatricians: A DBPNet Study.
    Harstad E; Blum N; Gahman A; Shults J; Chan E; Barbaresi W
    J Dev Behav Pediatr; 2016 Sep; 37(7):541-7. PubMed ID: 27429355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Young Children with Attention-Deficit/Hyperactivity Disorder and/or Disruptive Behavior Disorders Are More Frequently Prescribed Alpha Agonists Than Stimulants.
    Mittal S; Boan AD; Kral MC; Lally MD; van Bakergem K; Macias MM; LaRosa A
    J Child Adolesc Psychopharmacol; 2020 Mar; 30(2):81-86. PubMed ID: 31621385
    [No Abstract]   [Full Text] [Related]  

  • 4. Psychiatric comorbidities and use of psychotropic medications in people with autism spectrum disorder in the United States.
    Houghton R; Ong RC; Bolognani F
    Autism Res; 2017 Dec; 10(12):2037-2047. PubMed ID: 28963809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in Mental Health Diagnosis and Prescribing Across Pediatric Primary Care Practices.
    Mayne SL; Ross ME; Song L; McCarn B; Steffes J; Liu W; Margolis B; Azuine R; Gotlieb E; Grundmeier RW; Leslie LK; Localio R; Wasserman R; Fiks AG
    Pediatrics; 2016 May; 137(5):. PubMed ID: 27244791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Many Young Children with Autism Who Use Psychotropic Medication Do Not Receive Behavior Therapy: A Multisite Case-Control Study.
    Wiggins LD; Nadler C; Rosenberg S; Moody E; Reyes N; Reynolds A; Alexander A; Daniels J; Thomas K; Giarelli E; Levy SE
    J Pediatr; 2021 May; 232():264-271. PubMed ID: 33493493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy for the treatment of aggression in pediatric and adolescent patients with autism spectrum disorder comorbid with attention-deficit hyperactivity disorder: A questionnaire survey of 571 psychiatrists.
    Yamamuro K; Tsujii N; Ota T; Kishimoto T; Iida J
    Psychiatry Clin Neurosci; 2017 Aug; 71(8):554-561. PubMed ID: 28317224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common Use of Stimulants and Alpha-2 Agonists to Treat Preschool Attention-Deficit Hyperactivity Disorder: A DBPNet Study.
    Blum NJ; Shults J; Harstad E; Wiley S; Augustyn M; Meinzen-Derr JK; Wolraich ML; Barbaresi WJ
    J Dev Behav Pediatr; 2018 Sep; 39(7):531-537. PubMed ID: 29851669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of Autism Spectrum Disorder by Developmental-Behavioral Pediatricians in Academic Centers: A DBPNet Study.
    Hansen RL; Blum NJ; Gaham A; Shults J;
    Pediatrics; 2016 Feb; 137 Suppl 2():S79-89. PubMed ID: 26908481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care.
    Murray ML; Hsia Y; Glaser K; Simonoff E; Murphy DG; Asherson PJ; Eklund H; Wong IC
    Psychopharmacology (Berl); 2014 Mar; 231(6):1011-21. PubMed ID: 23681164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and predictors of psychotropic medication use in adolescents and adults with autism spectrum disorder in Italy: A cross-sectional study.
    Fusar-Poli L; Brondino N; Rocchetti M; Petrosino B; Arillotta D; Damiani S; Provenzani U; Petrosino C; Aguglia E; Politi P
    Psychiatry Res; 2019 Jun; 276():203-209. PubMed ID: 31102885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom.
    Houghton R; Liu C; Bolognani F
    Autism Res; 2018 Dec; 11(12):1690-1700. PubMed ID: 30380202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-Generation Antipsychotic Prescribing Patterns for Pediatric Patients Enrolled in West Virginia Medicaid.
    Melvin KE; Hart JC; Sorvig RD
    Psychiatr Serv; 2017 Oct; 68(10):1061-1067. PubMed ID: 28566023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder.
    Madden JM; Lakoma MD; Lynch FL; Rusinak D; Owen-Smith AA; Coleman KJ; Quinn VP; Yau VM; Qian YX; Croen LA
    J Autism Dev Disord; 2017 Jan; 47(1):144-154. PubMed ID: 27817163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotropic medication use among adolescents and young adults with an autism spectrum disorder: parent views about medication use and healthcare services.
    Lake JK; Vogan V; Sawyer A; Weiss JA; Lunsky Y
    J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):260-8. PubMed ID: 25803636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders.
    Mandell DS; Morales KH; Marcus SC; Stahmer AC; Doshi J; Polsky DE
    Pediatrics; 2008 Mar; 121(3):e441-8. PubMed ID: 18310165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing of psychotropic medications for children by Australian pediatricians and child psychiatrists.
    Efron D; Hiscock H; Sewell JR; Cranswick NE; Vance AL; Tyl Y; Luk ES
    Pediatrics; 2003 Feb; 111(2):372-5. PubMed ID: 12563066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics Associated with Drug Prescription and Compliance Among Young Children with Autism Spectrum Disorder.
    Meiri G; Azoulay H; Menashe I
    J Child Adolesc Psychopharmacol; 2018 Apr; 28(3):232-237. PubMed ID: 29266976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychotropic Polypharmacy Among Children and Youth Receiving Medicaid, 2012-2015.
    Lohr WD; Creel L; Feygin Y; Stevenson M; Smith MJ; Myers J; Woods C; Liu G; Davis DW
    J Manag Care Spec Pharm; 2018 Aug; 24(8):736-744. PubMed ID: 30058983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying clinically questionable psychotropic prescribing practices for medicaid recipients in new york state.
    Essock SM; Covell NH; Leckman-Westin E; Lieberman JA; Sederer LI; Kealey E; Finnerty MT
    Psychiatr Serv; 2009 Dec; 60(12):1595-602. PubMed ID: 19952148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.